New York State Psychiatric Institute in the Division on Substance Use Disorders is a clinical research site located in New York, New York, United States 10032.
Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.
New York State Psychiatric Institute in the Division on Substance Use Disorders has participated in 2 clinical trials.
Therapeutic areas: Opioid-use Disorder, Alcohol Use Disorder, Opioid Use Disorder.
Sponsors: New York State Psychiatric Institute.
Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
New York State Psychiatric Institute in the Division on Substance Use Disorders has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
New York State Psychiatric Institute in the Division on Substance Use Disorders has 2 clinical trials on record. Their work covers Opioid-use Disorder, Alcohol Use Disorder, Opioid Use Disorder.
New York State Psychiatric Institute in the Division on Substance Use Disorders has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.